These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34036848)

  • 1. Alpha-1 Antitrypsin Deficiency-Associated Clinical Manifestations and Healthcare Resource Use in the United States.
    Herrera EM; Joseph C; Brouwer ES; Gandhi V; Czorniak M
    COPD; 2021 Jun; 18(3):315-324. PubMed ID: 34036848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States.
    Sieluk J; Slejko JF; Silverman H; Perfetto E; Mullins CD
    Orphanet J Rare Dis; 2020 Sep; 15(1):260. PubMed ID: 32967697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare resource utilization and costs among patients with alpha-1 antitrypsin deficiency with liver and/or lung disease: a longitudinal retrospective study in the USA.
    Hagiwara M; Divino V; Munnangi S; Delegge M; Park S; Marins EG; Ren K; Strange C
    J Comp Eff Res; 2024 Jun; 13(6):e230186. PubMed ID: 38696696
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
    Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R;
    Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients.
    Karl FM; Holle R; Bals R; Greulich T; Jörres RA; Karch A; Koch A; Karrasch S; Leidl R; Schulz H; Vogelmeier C; Wacker ME;
    Respir Res; 2017 Apr; 18(1):60. PubMed ID: 28416015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis.
    Campos MA; Runken MC; Davis AM; Johnson MP; Stone GA; Buikema AR
    Adv Ther; 2018 Apr; 35(4):467-481. PubMed ID: 29616482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
    Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbations in subjects with alpha-1 antitrypsin deficiency receiving augmentation therapy.
    Campos MA; Alazemi S; Zhang G; Wanner A; Salathe M; Baier H; Sandhaus RA
    Respir Med; 2009 Oct; 103(10):1532-9. PubMed ID: 19464158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency.
    Jarosch I; Hitzl W; Koczulla AR; Wencker M; Welte T; Gloeckl R; Janciauskiene S; Kenn K
    Respir Med; 2017 Sep; 130():98-101. PubMed ID: 29206641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of Medical Care Among Augmentation Therapy Users and Non-Users with Alpha-1 Antitrypsin Deficiency in the United States.
    Sieluk J; Levy J; Sandhaus RA; Silverman H; Holm KE; Mullins CD
    Chronic Obstr Pulm Dis; 2018 Nov; 6(1):6-16. PubMed ID: 30775420
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha-1-Antitrypsin Deficiency: Disease Management and Learning from Studies.
    Greulich T
    COPD; 2017 Mar; 14(sup1):S8-S11. PubMed ID: 28306355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year Prevalence, Comorbidities, and Cost of Hospitalizations for Alpha-1 Antitrypsin Deficiency among Patients with Chronic Obstructive Pulmonary Disease in the United States.
    Blanchette CM; Zacherle E; Noone JM; Van Doren BA; Roy D; Howden R
    J Health Econ Outcomes Res; 2017; 5(1):65-74. PubMed ID: 37664693
    [No Abstract]   [Full Text] [Related]  

  • 13. Labelling Alpha-1 antitrypsin deficiency in the medical record - A call to action.
    Riley L; Lascano J
    Respir Med; 2022 Mar; 193():106749. PubMed ID: 35124356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and patient journey of Rett syndrome in the United States: a real-world evidence study.
    May D; Kponee-Shovein K; Mahendran M; Downes N; Sheng K; Lefebvre P; Cheng WY
    BMC Neurol; 2023 Apr; 23(1):141. PubMed ID: 37016355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening.
    Hiller AM; Piitulainen E; Tanash H
    Int J Chron Obstruct Pulmon Dis; 2022; 17():43-52. PubMed ID: 35023912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism.
    Basil N; Ekström M; Piitulainen E; Lindberg A; Rönmark E; Jehpsson L; Tanash H
    J Thromb Haemost; 2021 Jun; 19(6):1519-1525. PubMed ID: 33763945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of diagnosed α1-antitrypsin deficiency and its comorbidities: results from a large population-based database.
    Greulich T; Nell C; Hohmann D; Grebe M; Janciauskiene S; Koczulla AR; Vogelmeier CF
    Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 27824593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
    Lascano JE; Campos MA
    Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.